Hikal Ltd
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Hikal Limited is navigating a pivotal transition towards sustainable growth, bolstered by strategic investments in high-potency facilities and an expanding CDMO pipeline, particularly in light of the China+1 outsourcing trend. Management's focus on diversifying into higher-value specialty chemicals and personal care segments is expected to enhance revenue streams, with new product commercialization anticipated to contribute positively from FY27 onwards. However, challenges persist in the Crop Protection segment due to competitive pricing pressures and structural overcapacity, particularly from Chinese competitors. Despite these headwinds, improved order inflows signal a recovery in demand volumes. Vista's financial outlook reflects stable revenue growth consistent with historical performance, alongside improving margins as operational efficiencies are realized. The company's premium valuation, while indicative of investor confidence, suggests limited upside potential in the near term. Over the next 12-24 months, key opportunities include leveraging new facilities for enhanced production capabilities and expanding into international markets, while watchpoints include ongoing compliance issues and raw material cost pressures that could impact profitability
Why We Like This Stock
- Strategic investments in high-potency facilities are enhancing capabilities in complex chemistries
- Expansion of the CDMO pipeline aligns with global outsourcing trends, particularly the China+1 strategy
- New product commercialization in specialty chemicals is expected to contribute positively from FY27
Things To Watch Out For
- The Crop Protection segment faces competitive pricing pressures and structural overcapacity from Chinese competitors
- Ongoing compliance issues related to a U.S. FDA warning letter could hinder operational performance
- Elevated raw material costs due to geopolitical tensions may impact margins and profitability
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 1,785 | 1,860 | 1,713 | 1,803 | 1,846 |
| Profit Before Tax (Cr.) | 95 | 124 | 7 | -2 | 1 |
| PBT Margin | 5.3% | 6.7% | 40.9% | -0.1% | 0.0% |
| Net Profit (Cr.) | 68 | 94 | 33 | -1 | 1 |
| Earnings Per Share | 5.5 | 7.6 | 2.7 | -0.1 | 0.0 |
Analyst Recommendations
No analyst recommendations available.
Company Overview
Show Company Profile
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals indusries. It operates through two segments, Pharmaceuticals and Crop Protection. The company also manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. In addition, it offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. Further, the company provides anti-convulsant, anti-inflammatory, analgesic, Anti-parasitic, anti-lipemic, anti-histaminic, anti-depressant, anti-psychotic, anti-emetic, anti-diabetic, anti-thrombotic, Anti-viral, anti-hypertensive, and Haemorheologic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, insecticide, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. It operates in India, the United States, Canada, Europe, South East Asia, and internationally. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.